jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Nov. 02, 2010

Dec. 17, 2018

jRCT2080221293

An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult male

version:
date:

Sanwa Kagaku Kenkyusho Co., Ltd.

n_kuboyama@mb5.skk-net.com

Sanwa Kagaku Kenkyusho Co., Ltd.

n_kuboyama@mb5.skk-net.com

12

Interventional

Open-label, add-on study

3

Japanese healthy adult male

Patients with any disease
Subjects with any history of diseases that might affect the assessment in the study
Subjects expressing the CYP2C9*3 genotype

20age old over
39age old under

Male

Healthy adult male

investigational material(s)
Generic name etc : FYX-051
INN of investigational material :
Therapeutic category code : 394 Agents for treatment of gout
Dosage and Administration for Investigational material : Oral

Pharmacokinetics and Safety

SANWA KAGAKU KENKYUSHO CO.,LTD.
Fuji Yakuhin Co., Ltd.

JapicCTI-101330

History of Changes

No Publication date
5 Dec. 17, 2018 (this page) Changes
4 Dec. 21, 2011 Detail Changes
3 Dec. 21, 2011 Detail Changes
2 Nov. 02, 2010 Detail Changes
1 Nov. 02, 2010 Detail